000			02200 a2200601 4500
005			20250517004247.0
264		0	_c20150521
008			201505s 0 0 eng d
022			_a1096-0945
024	7		_a10.1016/j.yexmp.2014.11.010 _2doi
040			_aNLM _beng _cNLM
100	1		_aStojsic, Jelena
245	0	0	_aProlonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma. _h[electronic resource]
260			_bExperimental and molecular pathology _cFeb 2015
300			_a27-32 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xmetabolism
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aImmunoenzyme Techniques
650	0	4	_aLoss of Heterozygosity
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNeoplasm Grading
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aNeoplasm Staging
650	0	4	_aPTEN Phosphohydrolase _xgenetics
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aPrognosis
650	0	4	_aProto-Oncogene Proteins c-akt _xmetabolism
650	0	4	_aSignal Transduction
650	0	4	_aSurvival Rate
650	0	4	_aTOR Serine-Threonine Kinases _xmetabolism
700	1		_aStankovic, Tijana
700	1		_aStojkovic, Sonja
700	1		_aMilinkovic, Vedrana
700	1		_aDinic, Jelena
700	1		_aMilosevic, Zorica
700	1		_aMilovanovic, Zorka
700	1		_aTanic, Nikola
700	1		_aBankovic, Jasna
773	0		_tExperimental and molecular pathology _gvol. 98 _gno. 1 _gp. 27-32
856	4	0	_uhttps://doi.org/10.1016/j.yexmp.2014.11.010 _zAvailable from publisher's website
999			_c24403899 _d24403899